Chronic inflammatory facial dermatosis
Epidemiology
- Predominantly affects young women (20–45 years)
- Can occur in children and men
- Increasing incidence due to topical corticosteroid misuse
- More common in individuals with sensitive skin or atopic background
Aetiology
- Topical corticosteroids (most important trigger)
- Heavy cosmetics, moisturizers
- Microbial factors (Demodex, fusiform bacteria – contributory, not primary)
Pathophysiology
- Disruption of the epidermal barrier
- Steroid-induced vasodilation and follicular occlusion
- Inflammatory reaction around hair follicles
- Rebound inflammation after steroid withdrawal
Clinical presentation
Skin Lesions
- Multiple small erythematous papules and papulopustules
- Characteristic sparing of the vermilion border
- Background erythema and dryness
- Burning or tight sensation (pruritus uncommon)
Distribution
- Perioral region (most common)
- Periocular (then termed periorificial dermatitis)
🧩 Classification
- Classic perioral dermatitis
- Periorificial dermatitis (mouth, nose, eyes)
- Granulomatous perioral dermatitis (children; yellow-brown papules)
Investigations
- No routine laboratory tests required
- Skin biopsy (rare): perifollicular lymphocytic infiltrate
Management
General Measures (Cornerstone)
- Discontinue topical corticosteroids gradually
- Avoid cosmetics, heavy moisturizers, and irritants
Topical Treatment (First-line)
- Clindamycin Cream 1% 1-2x/day
- Erythromycin Cream 2-3% 1-2x/day
- Azaleic acid Cream 20% or Gel 15% 2x/day
- Adapalene Gel 0.1% 1x/day
Systemic Therapy
- Oral tetracyclines (doxycycline, minocycline) for moderate–severe cases
- Macrolides for children or pregnant patients